Ra Medical Systems Stock Forecast, Price & News

Ra Medical Systems (NYSE:RMED) Frequently Asked Questions

Is Ra Medical Systems a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ra Medical Systems in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Ra Medical Systems stock.
View analyst ratings for Ra Medical Systems or view top-rated stocks.

How has Ra Medical Systems' stock been impacted by Coronavirus (COVID-19)?

Ra Medical Systems' stock was trading at $31.4075 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, RMED stock has decreased by 96.3% and is now trading at $1.16.
View which stocks have been most impacted by COVID-19.

When is Ra Medical Systems' next earnings date?

Ra Medical Systems is scheduled to release its next quarterly earnings announcement on Monday, March 14th 2022.
View our earnings forecast for Ra Medical Systems.

How were Ra Medical Systems' earnings last quarter?

Ra Medical Systems, Inc. (NYSE:RMED) posted its quarterly earnings results on Monday, November, 15th. The company reported ($1.15) EPS for the quarter, missing the Zacks' consensus estimate of ($0.79) by $0.36. The company had revenue of $0.01 million for the quarter, compared to analysts' expectations of $0.70 million. Ra Medical Systems had a negative trailing twelve-month return on equity of 163.48% and a negative net margin of 813.96%.
View Ra Medical Systems' earnings history.

When did Ra Medical Systems' stock split? How did Ra Medical Systems' stock split work?

Ra Medical Systems shares reverse split on the morning of Tuesday, November 17th 2020. The 1-25 reverse split was announced on Monday, November 16th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Monday, November 16th 2020. An investor that had 100 shares of Ra Medical Systems stock prior to the reverse split would have 4 shares after the split.

What price target have analysts set for RMED?

2 brokers have issued 1 year price objectives for Ra Medical Systems' stock. Their forecasts range from $12.00 to $12.00. On average, they expect Ra Medical Systems' share price to reach $12.00 in the next year. This suggests a possible upside of 934.5% from the stock's current price.
View analysts' price targets for Ra Medical Systems or view top-rated stocks among Wall Street analysts.

Who are Ra Medical Systems' key executives?

Ra Medical Systems' management team includes the following people:

• Jonathan Will McGuire, Chief Executive Officer & Director
• Andrew C. Jackson, Chief Financial & Accounting Officer (LinkedIn Profile)
• Alvin Memmolo, VP-Clinical, Quality & Regulatory Affairs
• Christopher Folk, Vice President-Engineering
• Maria Villanueva Sessions, Vice President & Compliance Officer

Who are some of Ra Medical Systems' key competitors?

Some companies that are related to Ra Medical Systems include RenovaCare (RCAR), Neovasc (NVCN), Avinger (AVGR), PetVivo (PETV), ReShape Lifesciences (RSLS), Aethlon Medical (AEMD), Arch Therapeutics (ARTH), Vivos (RDGL), InspireMD (NSPR), Inspira Technologies Oxy B.H.N. (IINN), Motus GI (MOTS), Sigyn Therapeutics (SIGY), InVivo Therapeutics (NVIV), Dynatronics (DYNT) and Encision (ECIA).
View all of RMED's competitors.

What other stocks do shareholders of Ra Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ra Medical Systems investors own include Bionano Genomics (BNGO), Gran Tierra Energy (GTE), Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Cannabics Pharmaceuticals (CNBX), Novan (NOVN), OrganiGram (OGI), Pennsylvania Real Estate Investment Trust (PEI), CBL & Associates Properties (CBL) and Zosano Pharma (ZSAN).

When did Ra Medical Systems IPO?

(RMED) raised $50 million in an initial public offering (IPO) on Thursday, September 27th 2018. The company issued 3,300,000 shares at a price of $14.00-$16.00 per share. Piper Jaffray and Cantor served as the underwriters for the IPO and SunTrust Robinson Humphrey, Nomura and Maxim Group were co-managers.

What is Ra Medical Systems' stock symbol?

Ra Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "RMED."

How do I buy shares of Ra Medical Systems?

Shares of RMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ra Medical Systems' stock price today?

One share of RMED stock can currently be purchased for approximately $1.16.

How much money does Ra Medical Systems make?

Ra Medical Systems has a market capitalization of $8.15 million and generates $4.41 million in revenue each year. The company earns $-36.04 million in net income (profit) each year or ($8.04) on an earnings per share basis.

How many employees does Ra Medical Systems have?

Ra Medical Systems employs 85 workers across the globe.

What is Ra Medical Systems' official website?

The official website for Ra Medical Systems is www.ramed.com.

Where are Ra Medical Systems' headquarters?

Ra Medical Systems is headquartered at 2070 Las Palmas Drive, Carlsbad CA, 92011.

How can I contact Ra Medical Systems?

Ra Medical Systems' mailing address is 2070 Las Palmas Drive, Carlsbad CA, 92011. The company can be reached via phone at (760) 804-1648 or via email at [email protected].